newsfilter
← Latest News
PR Newswire·

From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch

LIXTGEVVSTTLNCEG
  • LIXTE Biotechnology Holdings, Inc. (NASDAQ: LIXT) is executing a total corporate reinvention in June 2026 by pivoting from a clinical-stage cancer-drug developer to a power-infrastructure company.
  • The company has entered a definitive agreement to acquire 100% of NOMAD Transportable Power Systems, Inc., a market leader in deployable, utility-grade battery energy storage.
  • Upon closing the acquisition, LIXTE intends to rename itself NOMAD Power Solutions & reposition as a "power availability platform."
  • The strategic shift was announced in June 2026 with the appointment of Stuart D. Porter from Denham Capital to the board to lead the transformation into AI energy infrastructure.
  • LIXTE plans to seek a buyer for its existing clinical-stage oncology & med-tech operations to fully exit the biotechnology sector.
  • The pivot addresses a projected 224 gigawatt rise in North American summer peak demand over the next decade & a NERC Level 3 Alert regarding grid reliability risks from large computational loads.
  • NOMAD's core value proposition is its transportable, utility-grade 1 megawatt battery system which bypasses the lengthy permitting, environmental reviews, & interconnection queue delays associated with permanent infrastructure.
  • NOMAD's platform utilizes UL 9540-validated lithium iron phosphate chemistry with integrated fire suppression & AI-assisted 24/7 monitoring.
  • NOMAD's manufacturing capacity is projected to scale from roughly 2.5 gigawatts in 2026 to 3.5 gigawatts in 2027.
  • Management projects revenue growth of approximately 175% in 2025, 135% in 2026, & over 285% in 2027, though these figures are unaudited projections.
  • LIXTE aims to build a recurring-revenue business model featuring fleet monitoring, Energy-as-a-Service, software-enabled asset management, & capacity leasing.
  • The company positions itself against larger industry peers including GE Vernova (NYSE: GEV), Vistra Corp (NYSE: VST), Talen Energy (NASDAQ: TLN), & Constellation Energy (NASDAQ: CEG).
  • NOMAD claims to have pioneered the deployable utility-grade BESS category as the first to bring a mobile system meeting strict utility standards to market.
  • The acquisition remains subject to customary closing conditions, & the final transaction consideration, structure, & timing have not yet been finalized.
  • The transformation carries significant execution, integration, & financing risks due to the speculative nature of a small-cap biotech pivoting to infrastructure overnight.